- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Oxonica Ltd announces today that its chief executive, Dr. Kevin Matthews has been appointed to the Board of Elementis plc, as a non-executive director with effect from 16th February 2005.
Oxonica Limited is a leading European technology group, with products already launched into the global market.
The company was spun-out in 1999 from the University of Oxford and is based in Oxford, England. Oxonica currently employs 30 professional staff and is lead by a strong and commercially experienced management team.
Oxonica’s mission is to develop commercial solutions from nanotechnology. It owns a diverse portfolio of demand driven products that offer substantial benefits to the target markets of environmental, healthcare and materials.
Lead products include:
Oxonica is also active in searching for the next generation of products and is already engaged in developing transformational detection technologies which will enable a new generation of diagnostic products for the clinical diagnostic and life science markets.
In addition, the company is developing other UV absorber technologies into polymer systems and coatings, based on similar technologies to that used in Optisol™.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Designing ultrasound tools with Lego-like proteins August 29th, 2016